JANSSEN
Career Opportunities
Janssen Medical Information Website 		family
family
Important information on CAELYX® (pegylated liposomal doxorubicin) 20 mg and 50 mg vials
Important information on VELCADE® (bortezomib mannitol boronic ester for injection) 3.5mg/vial
Important Changes to the Dose Conversion Guidelines for DURAGESIC* fentanyl transdermal system
New Safety Information regarding Needle Assembly of RISPERDAL* CONSTA* (risperidone)
© Janssen Inc. 2000 - 2012    Date Last Updated 12/26/2011
This site is published by Janssen Inc. which is solely responsible
for its contents. It is intended only for visitors from Canada.		 Search | Site Map | Feed Back | Privacy | Francais | Legal Notice